SV-BR-1-GM
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SV-BR-1-GM, covering 2021-01-29 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Combination Study of SV-BR-1-GM With Retifanlimab [Phase 1, Phase 2]